Evidence map›Paper›PMID 19023113›Full record

ArticleBlood2009

Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targeting.

Nancy S Longo, Patricia L Lugar, Sule Yavuz, Wen Zhang, Peter H L Krijger, Daniel E Russ, Dereje D Jima, Sandeep S Dave, Amrie C Grammer, Peter E Lipsky

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expression.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Nancy S LongoAutoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892-1560, USA.
Patricia L Lugar
Sule Yavuz
Wen Zhang
Peter H L Krijger
Daniel E Russ
Dereje D Jima
Sandeep S Dave
Amrie C Grammer
Peter E Lipsky
National Institute of Arthritis and Musculoskeletal and Skin Diseases · USDuke University · USNational Institutes of Health · US

Funding

Text Analytics, Machine Learning & High Performance ComputingZIHCT000200 · CIT · CENTER FOR INFORMATION TECHNOLOGY · PI JOHNSON, CALVIN A · 2009 to 2019
$25.5M
B CELL REPERTOIRE ANALYSISZ01AR041127 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI PLOTZ, PAUL · 2000 to 2008
$2.1M
B Cell Repertoire AnalysisZIAAR041127 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI PLOTZ, PAUL · 2009 to 2009
$247k
6 · The paper itself

Abstract

Subjects with X-linked hyper-IgM syndrome (X-HIgM) have a markedly reduced frequency of CD27(+) memory B cells, and their Ig genes have a low level of somatic hypermutation (SHM). To analyze the nature of SHM in X-HIgM, we sequenced 209 nonproductive and 926 productive Ig heavy chain genes. In nonproductive rearrangements that were not subjected to selection, as well as productive rearrangements, most of the mutations were within targeted RGYW, WRCY, WA, or TW motifs (R = purine, Y = pyrimidine, and W = A or T). However, there was significantly decreased targeting of the hypermutable G in RGYW motifs. Moreover, the ratio of transitions to transversions was markedly increased compared with normal. Microarray analysis documented that specific genes involved in SHM, including activation-induced cytidine deaminase (AICDA) and uracil-DNA glycosylase (UNG2), were up-regulated in normal germinal center (GC) B cells, but not induced by CD40 ligation. Similar results were obtained from light chain rearrangements. These results indicate that in the absence of CD40-CD154 interactions, there is a marked reduction in SHM and, specifically, mutations of AICDA-targeted G residues in RGYW motifs along with a decrease in transversions normally related to UNG2 activity.

Indexed as

AdolescentAdultAICDA (Activation-Induced Cytidine Deaminase)B-LymphocytesCD40 AntigensCD40 LigandChildCytidine DeaminaseDNA GlycosylasesDNA Mutational AnalysisGene Expression Regulation, EnzymologicGerminal CenterHumansHyper-IgM Immunodeficiency Syndrome, Type 1Immunoglobulin Heavy ChainsImmunologic CappingAICDA (Activation-Induced Cytidine Deaminase)CCNO protein, humanCD40 AntigensCD40 LigandCytidine DeaminaseDNA GlycosylasesImmunoglobulin Heavy Chains

Identifiers

PMID19023113
PMCPMC2670789
OpenAlexW1976028093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.